MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss and
comprehensive loss
-$30,375K
Net loss before
income taxes
-$29,940K
Income tax expense
$435K
Product
$117,100K
Royalty
$1,613K
Loss from operations
-$21,536K
Total other (expense)
income
-$8,404K
Total revenues
$118,713K
Interest income
$2,665K
Other gain, net
$180K
Total costs and
expenses
$140,249K
Loss on assertio
therapeutics divestiture
-$8,174K
Interest expense
$3,075K
Change in fair value of
contingent consideration
-$276K
Selling, general and
administrative expenses
$69,000K
Cost of sales
$35,383K
Amortization of intangible
assets
$29,863K
Restructuring charges
$2,889K
Impairment of intangible
assets
$1,700K
Research and development
expenses
$1,690K
Back
Back
Income Statement
source: myfinsight.com
Assertio Holdings, Inc. (ASRT)
Assertio Holdings, Inc. (ASRT)